GenScript

[𝗨𝗦] This week, we welcomed our newest team members with #GenConnect, where new hires meet the team, explore our labs, and see firsthand what it means to be part of GenScript! From leadership-led company and department overviews to office and lab tours that brought our work to life, our new hires got a front-row look at our New Jersey office. But the highlight? Building 3 bikes together to donate to local churches for children in need. Because the best way to start a new chapter is by giving back. We wrapped things up with an evening at Topgolf (turns out scientists have some surprisingly competitive swings)🏌️ Welcome to the team. We're so lucky to have you all! #GenScript #NewHires #LifeAtGenScript #GenScriptCareers

Proud to have the GenScript team represented at a recent 𝗦&𝗣 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗬𝗲𝗮𝗿𝗯𝗼𝗼𝗸 𝟮𝟬𝟮𝟲 Distinction Ceremony, which recognized leading companies for their performance in sustainability and corporate responsibility. This recognition is meaningful: of the more than 9,200 companies assessed and eligible for inclusion in the 2026 Yearbook, only 848 achieved Yearbook membership. Even more encouraging, GenScript saw an 82% improvement in its sustainability performance since past year, based on S&P Global's assessment of ESG management. The event brought together organizations from across industries, providing an opportunity for colleagues in attendance to exchange insights with peers and celebrate advances on shared environmental and social priorities. We’re honored to contribute to this collective progress – and to be part of a global community working toward a more sustainable and resilient future. #GenScript #SPGSustainable1Yearbook #SustainableYearbook2026 #Sustainability #ESG

Global scale is no longer enough in biotech. Global reliability is. In a new article, GenScript Co-Founder Frank Zhang shares why consistent, transparent, standardized delivery is the real differentiator, and what it takes to build systems that hold under pressure. Because when delivery isn’t consistent, the consequences ripple beyond operations – to partners, customers, and ultimately patients. 👉 Read more: https://bit.ly/4uGoCQC #GenScript #Biotech #Leadership #ScriptingPossibilities

With GenScript’s 𝗚𝗲𝗻𝗕𝗿𝗶𝗰𝗸™, long DNA no longer slows your workflow. From rapid delivery at 10 kb to constructs up to 200 kb, get fully synthesized long DNA with guaranteed sequence accuracy. You design. We deliver. No surprises. It matters who makes your genes. 𝗚𝗲𝗻𝗦𝗰𝗿𝗶𝗽𝘁 𝗶𝘁. Get started with GenBrick™: https://lnkd.in/e5Br75DU *𝘛𝘶𝘳𝘯𝘢𝘳𝘰𝘶𝘯𝘥 𝘵𝘪𝘮𝘦 𝘮𝘢𝘺 𝘷𝘢𝘳𝘺 𝘣𝘢𝘴𝘦𝘥 𝘰𝘯 𝘲𝘶𝘢𝘭𝘪𝘧𝘺𝘪𝘯𝘨 𝘴𝘦𝘲𝘶𝘦𝘯𝘤𝘦𝘴, 𝘴𝘦𝘲𝘶𝘦𝘯𝘤𝘦 𝘤𝘰𝘮𝘱𝘭𝘦𝘹𝘪𝘵𝘺 𝘢𝘯𝘥 𝘱𝘳𝘰𝘫𝘦𝘤𝘵 𝘴𝘱𝘦𝘤𝘪𝘧𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴. #GenScript #ScriptingPossibilities #GenBrick #SyntheticBiology #GeneSynthesis #LongDNA

[𝗘𝗨] We’re excited to be attending 𝗜𝗢𝗣𝗖 𝟮𝟬𝟮𝟲 in Athens! Join GenScript at 𝗕𝗼𝗼𝘁𝗵 #𝟯, taking place 𝗝𝘂𝗻𝗲 𝟵–𝟭𝟭, 𝟮𝟬𝟮𝟲, at 𝗧𝗶𝘁𝗮𝗻𝗶𝗮 𝗛𝗼𝘁𝗲𝗹 𝗔𝘁𝗵𝗲𝗻𝘀, 𝗚𝗿𝗲𝗲𝗰𝗲. Discover how we’re scripting possibilities across oligonucleotide and peptide research, cyclic peptide synthesis, bioconjugation, and peptide-drug conjugate development — partnering with scientists to move programs forward with tailored solutions and expert support. 𝙑𝙞𝙚𝙬 𝙤𝙪𝙧 𝙖𝙜𝙚𝙣𝙙𝙖: https://bit.ly/4uIwtxa Don’t miss our spotlight presentation: 🎤 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗖𝘆𝗰𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗖𝗼𝗻𝗷𝘂𝗴𝗮𝘁𝗶𝗼𝗻 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗶𝗻 𝗣𝗲𝗽𝘁𝗶𝗱𝗲 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 Presenter: Dr. Hong Li, VP of Production and R&D Center II ⏰ 11:55 AM–12:10 PM EEST | 11 June 2026 We’re also taking part in two poster presentations: 📅 𝗜𝗺𝗽𝗿𝗼𝘃𝗲𝗱 𝗖𝘆𝗰𝗹𝗶𝗰 𝗣𝗲𝗽𝘁𝗶𝗱𝗲 𝗦𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀 𝗮𝗻𝗱 𝗥𝗼𝗯𝘂𝘀𝘁 𝗖𝗼𝗻𝗷𝘂𝗴𝗮𝘁𝗶𝗼𝗻 𝗧𝗲𝗰𝗵𝗻𝗶𝗾𝘂𝗲𝘀 𝗳𝗼𝗿 𝗣𝗗𝗖𝘀 Presenter: Dr. Hong Li, VP of Production and R&D Center II Track: Peptides 📅 𝗘𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴 𝗕𝗶𝗼𝗰𝗼𝗻𝗷𝘂𝗴𝗮𝘁𝗶𝗼𝗻 𝗖𝗵𝗲𝗺𝗶𝘀𝘁𝗿𝘆 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗼𝗳 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆-𝗢𝗹𝗶𝗴𝗼𝗻𝘂𝗰𝗹𝗲𝗼𝘁𝗶𝗱𝗲 𝗖𝗼𝗻𝗷𝘂𝗴𝗮𝘁𝗲𝘀 Presenter: Johanne Mbianda, FAS Track: Oligonucleotides Stop by 𝗕𝗼𝗼𝘁𝗵 #𝟯 to meet the GenScript team and discuss how we can support your oligonucleotide and peptide programs with tailored solutions and expert support. Abigail McLaughlin-Gallagher | Lobna Medfai, PhD | Arianna Campagnaro Let’s connect and script the future of biologics together. #GenScript #IOPC2026 #Oligonucleotides #Peptides #Bioconjugation #PeptideSynthesis

[𝗨𝗦] A wonderful afternoon of connection, conversation, and community at our #GenScriptLive: Lux Unwind Networking in South San Francisco 🙌 It was fantastic seeing members of our community come together for an afternoon of networking and unwinding after a busy day. From engaging discussions to new connections over food and drinks, the energy throughout the event was amazing! ✨ Thank you to everyone who joined us and made the afternoon so memorable. Your energy and engagement made the event truly special! Special shoutout to our amazing team: Nicole Ford, PhD, Garrett Musil, Menglu (Karen) Han, Mark Shulewitz, Amy Braun, Ishita Barman, Xian (Jarod) Li, Li Li, Sherry Weems, Sydney Mikulec, MS, Wei (Vevian) Zhang Stay tuned! More #GenScriptLive events are on the way 👉 https://lnkd.in/esNAvM-n #GenScript #ScriptingPossibilities #Networking #Biotech #SanFrancisco

🚀 Every discovery needs a launchpad, and there’s no better time to upgrade your in-house protein expression workflow. With the 𝗧𝘂𝗿𝗯𝗼𝗖𝗛𝗢™ 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗘𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗞𝗶𝘁, you can go from sequence to protein at rocket speed—achieving a 3-7 day expression timeline with consistent, peak performance across all antibody formats. 𝙁𝙖𝙨𝙩𝙚𝙧 𝙚𝙭𝙥𝙧𝙚𝙨𝙨𝙞𝙤𝙣, 𝙛𝙖𝙨𝙩𝙚𝙧 𝙙𝙖𝙩𝙖, 𝙛𝙖𝙨𝙩𝙚𝙧 𝙙𝙚𝙘𝙞𝙨𝙞𝙤𝙣𝙨. It’s more than just a kit; it’s your launchpad for faster antibody discovery, right from your own bench. 𝗗𝗼𝗻'𝘁 𝗺𝗶𝘀𝘀 𝗼𝘂𝘁: Our exclusive 𝟯𝟬% 𝗢𝗙𝗙 launch offer for first-time orders is still available! You have 𝘂𝗻𝘁𝗶𝗹 𝗝𝘂𝗹𝘆 𝟭𝟭𝘁𝗵 to take advantage of this discount and experience uncompromised speed and yield. Ready for liftoff? Secure your kit and accelerate your research today: https://bit.ly/4uapCw7 #GenScript #TurboCHOorNothing #TurboCHOKit #ProteinExpression #AntibodyDrugDiscovery #AIDrugDiscovery

[𝗘𝗨] 𝐖𝐞’𝐫𝐞 𝐥𝐢𝐯𝐞 𝐚𝐭 𝐀𝐄𝐓 𝟮𝟬𝟮𝟲! 🚀   Stop by 𝐁𝐨𝐨𝐭𝐡 𝟏𝟎 to connect with our scientists and solution specialists, explore our latest innovations, and discuss how we can co-create solutions tailored to your research.   𝐌𝐞𝐞𝐭 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦: Hanying Luo, Dr. Lucas Siow, Guillermo Fernández, PhD, Rita Oliveira, Olivier Binggeli, Cleandra Gregório, PhD, and Chen(Lyla) Li.   Together, let's explore the future of antibody engineering!   #AET2026 #AntibodyEngineering #TurboCHOKit #TurboCHOorNothing #ScriptingPossibilities #GenScript

[𝗨𝗦/𝗖𝗮𝗻𝗮𝗱𝗮] 📞 𝗟𝗮𝘀𝘁 𝗖𝗮𝗹𝗹: 𝟮𝟱% 𝗢𝗙𝗙 – Expiring May 31st! Whether it’s Gene Synthesis, Peptides, IVT RNA, siRNA/ASO, ready-to-use Antibodies, or Proteins, take advantage of this exclusive opportunity before it ends this week! Order Now: https://bit.ly/4w1VAfg #GenScript #Promotion #ResearchSupport

[𝗔𝗣𝗔𝗖] 🎥 Upcoming Webinar Alert! Join us for an insightful session: "𝗘𝘅𝗽𝗹𝗼𝗿𝗶𝗻𝗴 𝗢𝗹𝗶𝗴𝗼𝗻𝘂𝗰𝗹𝗲𝗼𝘁𝗶𝗱𝗲-𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗖𝗼𝗻𝗷𝘂𝗴𝗮𝘁𝗶𝗼𝗻: 𝗧𝗵𝗲 𝗡𝗲𝘅𝘁 𝗦𝘁𝗲𝗽 𝗶𝗻 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻" and learn how these technology can enhance the development of siRNA or ASO based therapy. 📅 𝗗𝗮𝘁𝗲: May 26th, 2026 ⏰ 𝗧𝗶𝗺𝗲: 14:00PM KST 🌐 𝗟𝗮𝗻𝗴𝘂𝗮𝗴𝗲: Korean ✨ 웨비나 안내: 올리고뉴클레오타이드-항체 결합 기술의 발전: siRNA 및 ASO 기반 치료제 개발 이번 웨비나는 올리고뉴클레오타이드-항체 결합 기술의 발전을 탐구하며, siRNA 및 ASO 기반 치료제 개발에 초점을 맞춥니다. 주요 주제로는 특정 유전자를 타겟으로 하는 올리고뉴클레오타이드 서열의 AI 기반 설계, 대규모 및 고효율 합성 방법, 부위 특이적 결합 기술, 그리고 효과적인 스크리닝 및 분석을 위한 기능적 테스트 워크플로우가 포함됩니다. 📅 일정: 2026년 5월 26일 ⏰ 시간: 오후 2시 🌐 한국어로 진행 📌 웨비나 종료 후 설문조사에 참여해 주신 분들께는 감사의 의미로 모바일 커피 쿠폰을 보내 드릴 예정입니다. 등록링크: https://bit.ly/3PxScZi #GenScript #Webinar #Oligonucleotide #siRNA #ASO #AOC